Pileus 50 mg (Capsule)

Unit Price: ৳ 8.00 (2 x 10: ৳ 160.00)
Strip Price: ৳ 80.00

Medicine Details

Category Details
Generic Fluconazole
Company One pharma ltd
Also available as

Indications

  • Vaginal Candidiasis
  • Oropharyngeal Candidiasis
  • Oesophageal Candidiasis
  • Tinea corporis
  • Tinea cruris
  • Tinea pedis
  • Kerion
  • Pityriasis versicolor
  • Onychomycosis
  • Invasive candidal infections
  • Cryptococcal infections
  • Prevention of cryptococcal meningitis
  • Prevention of fungal infections in immunocompromised patients
  • Systemic Candidiasis
  • Fungal urinary tract infections
  • Disseminated candidiasis
  • Prophylaxis for fungal infection in neutropenic cancer patients
  • Acute treatment of other systemic fungal infections such as coccidioidomycosis and histoplasmosis

Pharmacology

  • Triazole antifungal agent
  • Potent inhibitor of fungal cytochrome P-450 dependent enzymes
  • Responsible for the synthesis of ergosterol

Dosage & Administration

  • Adults:
    • 150 mg as a single dose for Vaginal Candidiasis
    • 200 mg in 1st day followed by 100 mg daily for 14 days for Oropharyngeal Candidiasis
    • 200 mg in 1st day followed by 100 mg daily for 14-30 days for Oesophageal Candidiasis
    • 150 mg weekly for 4-6 weeks for Tinea corporis/Tinea cruris/Tinea pedis/Other Tinea
    • 50 mg daily for 20 days for Kerion
    • 400 mg as a single dose for Pityriasis versicolor
    • 150 mg weekly for 12 months for Onychomycosis
    • Orally or by IV infusion, 400 mg on 1st day then 200-400 mg daily for Invasive candidal infections and cryptococcal infections
    • Orally or by IV infusion, 200 mg daily for Prevention of cryptococcal meningitis
    • Orally or by IV infusion, 50-400 mg daily for Prevention of fungal infections in immunocompromised patients
  • Children over 1 year:
    • 1-2 mg/kg daily for Superficial Candidiasis
    • 3-6 mg/kg daily for Systemic Candidiasis & Cryptococcal infection
  • Specific Population:
    • Elderly patient: Normal dose if no evidence of renal impairment
    • Renal Impairment:
      • Creatinine clearance (>41 ml/min): Dosage interval (hours) 24
      • Creatinine clearance (21-40 ml/min): Dosage interval (hours) 48
      • Creatinine clearance (10-20 ml/min): Dosage interval (hours) 72
      • Patients receiving regular dialysis: One dose after every dialysis session
    • Children: Renal clearance in children may be proportionately more rapid than in adults

Interaction

  • Increases prothrombin time after warfarin administration
  • Prolongs the serum half-life of oral sulphonyl ureas
  • Increases plasma concentrations of fuconazole by 40% when co-administered with hydrochlorothiazide
  • May increase the level of phenytoin to a clinically significant degree when co-administered with phenytoin
  • May decrease cyclosporin levels when co-administered with rifampicin

Contraindications

Known hypersensitivity to Fluconazole or to related triazole compounds

Side Effects

  • Nausea
  • Abdominal discomfort
  • Diarrhoea
  • Flatulence
  • Rash (Incidence less than 1%)
  • Anaphylaxis (rare)

Pregnancy & Lactation

Not recommended in pregnancy or in women of child bearing potential unless adequate contraception is employed

Precautions & Warnings

  • Abnormalities of hepatic, renal, haematological and other biochemical function tests in some patients
  • Rarely observed hepatic necrosis
  • Rarely developed exfoliative cutaneous reactions
  • Not recommended during lactation
  • Unlikely to impair a patient's ability to drive or use machinery

Use in Special Populations

  • Elderly: Normal dose should be used if no evidence of renal impairment
  • Renal Impairment:
    • CrCl >40: Dosage interval 24 hours (normal dosage regimen)
    • CrCl 21-40: Dosage interval 48 hours or half normal daily dose
    • CrCl 10-20: Dosage interval 72 hours or one-third normal daily dose
    • Patients receiving haemodialysis: One dose after every dialysis session

Overdose Effects

Supportive measures and symptomatic treatment, with forced volume diuresis recommended

Therapeutic Class

Drugs for subcutaneous and mycoses

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children

Related Brands